Paper30422751
Vanillic acid mitigates the ovalbumin (OVA)-induced asthma in rat model through prevention of airway inflammation.
Bai F and 5 others. Biosci Biotechnol Biochem, 2019. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Vanillic acid mitigates the ovalbumin (OVA)-induced asthma in rat model through prevention of airway inflammation. Papers, record 30422751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30422751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Vanillic acid mitigates the ovalbumin (OVA)-induced asthma in rat model through prevention of airway inflammation.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Asthma | Major topic |
| Lung | Major topic |
| Ovalbumin | Major topic |
| Vanillic Acid | Major topic |
| Animals | |
| Antioxidants | |
| Bronchoalveolar Lavage Fluid | |
| Disease Models, Animal | |
| Immunoglobulin E | |
| Inflammation | |
| Male | |
| Malondialdehyde | |
| Organ Size | |
| Rats | |
| Rats, Sprague-Dawley |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42770100 | Therapeutic effects of Zataria multiflora Boiss. extract-loaded chitosan nanoparticles against asthma in rats. | Avicenna J Phytomed | 2026 | https://conductscience.org/library/papers/42770100 | PubMed |
| 40563342 | Natural Hydroxybenzoic and Hydroxycinnamic Acids Derivatives: Mechanisms of Action and Therapeutic Applications. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40563342 | PubMed |
| 40519246 | The Effect of Linarin on Relevant Inflammatory Markers in Ovalbumin-Induced Asthma Rat Models. | Dose Response | 2025 | https://conductscience.org/library/papers/40519246 | PubMed |
| 40486901 | Blockade of cysteinyl leukotriene receptor 1 alleviates asthma by inhibiting bronchial epithelial cell apoptosis and activating the Nrf2 signaling pathway. | Exp Ther Med | 2025 | https://conductscience.org/library/papers/40486901 | PubMed |
| 40206073 | Bioactivity and biomedical applications of pomegranate peel extract: a comprehensive review. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40206073 | PubMed |
| 39961907 | Vanillic acid ameliorates collagen-induced arthritis by suppressing the inflammation response via inhibition of the MAPK and NF-κB signaling pathways. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/39961907 | PubMed |
| 39942571 | Antioxidant and Anti-Inflammatory Effects of Vanillic Acid in Human Plasma, Human Neutrophils, and Non-Cellular Models In Vitro. | Molecules | 2025 | https://conductscience.org/library/papers/39942571 | PubMed |
| 39775208 | Anti-tumor role and molecular mechanism of vanillic acid. | Discov Oncol | 2025 | https://conductscience.org/library/papers/39775208 | PubMed |
| 39459282 | Antimicrobial Properties and Therapeutic Potential of Bioactive Compounds in Nigella sativa: A Review. | Molecules | 2024 | https://conductscience.org/library/papers/39459282 | PubMed |
| 39263346 | An Updated Comprehensive Review of Plants and Herbal Compounds with Antiasthmatic Effect. | Evid Based Complement Alternat Med | 2024 | https://conductscience.org/library/papers/39263346 | PubMed |
| 38882318 | Revealing the mechanism and efficacy of natural products on treating the asthma: Current insights from traditional medicine to modern drug discovery. | Heliyon | 2024 | https://conductscience.org/library/papers/38882318 | PubMed |
| 38765036 | Knowledge mapping of links between dendritic cells and allergic diseases: A bibliometric analysis (2004-2023). | Heliyon | 2024 | https://conductscience.org/library/papers/38765036 | PubMed |
| 37107297 | Adenophora Stricta Root Extract Alleviates Airway Inflammation in Mice with Ovalbumin-Induced Allergic Asthma. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37107297 | PubMed |
| 36615843 | Selected Seeds as Sources of Bioactive Compounds with Diverse Biological Activities. | Nutrients | 2022 | https://conductscience.org/library/papers/36615843 | PubMed |
| 36234854 | Canavalia gladiata Pod Extract Mitigates Ovalbumin-Induced Asthma Onset in Male BALB/c Mice via Suppression of MAPK. | Molecules | 2022 | https://conductscience.org/library/papers/36234854 | PubMed |
| 35883867 | Adenophora Stricta Root Extract Protects Lung Injury from Exposure to Particulate Matter 2.5 in Mice. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/35883867 | PubMed |
| 35573886 | Anti-inflammatory and analgesic properties of Moroccan medicinal plants: Phytochemistry, in vitro and in vivo investigations, mechanism insights, clinical evidences and perspectives. | J Pharm Anal | 2022 | https://conductscience.org/library/papers/35573886 | PubMed |
| 35514705 | Methyl divanillate: redox properties and binding affinity with albumin of an antioxidant and potential NADPH oxidase inhibitor. | RSC Adv | 2019 | https://conductscience.org/library/papers/35514705 | PubMed |
| 34595237 | Network Pharmacology-Based Identification of Potential Targets of Lonicerae japonicae Flos Acting on Anti-Inflammatory Effects. | Biomed Res Int | 2021 | https://conductscience.org/library/papers/34595237 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30422751
GET https://conductscience.org/api/papers/v1/30422751/authors